Insider · CIK 0001889334
Ilya M Rachman
Files at IMMX (Immix Biopharma, Inc.). First filing Jun 20, 2025, latest Dec 10, 2025.
In brief
Ilya M Rachman files SEC Form 4 as CEO, chair and director at IMMX (Immix Biopharma, Inc.). Since Jun 20, 2025, Ilya M Rachman has reported 3 open-market buys worth $15k and 0 open-market sells worth $0, the latest filed on Dec 10, 2025.
A track record needs three past buys with six months of prices behind them; Ilya M Rachman has 0, so none is measured yet.
The newest scored trade: bought $4,976 of IMMX on Dec 10, 2025, filed Dec 10, 2025, scored 33 (weak). In the last 12 months: 1 buy worth $4,976 and 0 sells worth $0.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
IMMX: Immix Biopharma, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 33Weak | Immix Biopharma, Inc. | $4,976 746 shares | +0% | +395% from low0% from high | |
| 36Weak | Immix Biopharma, Inc. | $5,050 2,500 shares | +0% | +46% from low-34% from high | |
| 28Weak | Immix Biopharma, Inc. | $4,999 2,178 shares | +0% | +78% from low-8% from high |
Transactions
Every row this insider has filed, 5 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| May 22, 2026 | IMMX Immix Biopharma, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +500,000 | $0.00 | $0 | 500,000 | May 29, 2026 |
| Dec 10, 2025 | IMMX Immix Biopharma, Inc. | POpen-market purchase Common Stock | +746 | $6.67 | $4,976 | 1,141,683 | Dec 10, 2025 |
| Sep 17, 2025 | IMMX Immix Biopharma, Inc. | POpen-market purchase Common Stock | +2,500 | $2.02 | $5,050 | 1,140,937 | Sep 17, 2025 |
| Jun 20, 2025 | IMMX Immix Biopharma, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +340,000 | $0.00 | $0 | 340,000 | Jun 23, 2025 |
| Jun 18, 2025 | IMMX Immix Biopharma, Inc. | POpen-market purchase Common Stock | +2,178 | $2.30 | $4,999 | 1,138,437 | Jun 20, 2025 |
Questions about Ilya M Rachman
Answered from the filings on this page, as of the latest one.
Is Ilya M Rachman buying or selling?
In the last 12 months Ilya M Rachman reported 1 open-market buy worth $4,976 and 0 open-market sells worth $0 on SEC Form 4; the latest was bought $4,976 of IMMX on Dec 10, 2025. Grants, option exercises and tax withholding are not counted.
How did Ilya M Rachman's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Ilya M Rachman has 0.
Where does Ilya M Rachman file Form 4?
Ilya M Rachman has filed Form 4 at IMMX (Immix Biopharma, Inc.) as CEO and Chairman. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.